-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Kairos Pharma, LTD. quarterly/annual Amortization of Intangible Assets history and change rate from 2023 to Q1 2025.
- Kairos Pharma, LTD. Amortization of Intangible Assets for the quarter ending 31 Mar 2025 was $40K, unchanged year-over-year.
- Kairos Pharma, LTD. annual Amortization of Intangible Assets for 2024 was $160K, unchanged from 2023.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)